Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye

Value in Health

Volumn 8, Issue 2, 2005, Pages 168-174

  Rajagopalan, Krithika ^a,b   Abetz, Linda ^c   Mertzanis, Polyxane ^c   Espindle, Derek ^c   Begley, Carolyn ^d   Chalmers, Robin ^e   Caffery, Barbara ^f   Snyder, Christopher ^g   Nelson, J Daniel ^h   Simpson, Trefford ⁱ   Edrington, Timothy ^j  

^a ASTRAZENECA   (United Kingdom)

^b K Venkataraman of Alton Labs   (United States)

^c MAPI VALUES   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Clinical Trial Consultant   (United States)

^f University of Alabama ^*

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF WATERLOO   (Canada)

^j SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

more..

Author keywords

Dry eye; Impact of Dry Eye on Everyday Life (IDEEL); Keratoconjunctivitis Sicca; Quality of life; SF 36; Sj gren's Syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; EUROPEAN QUALITY OF LIFE QUESTIONNAIRE 5D; FEMALE; HUMAN; IMPACT OF DRY EYE ON EVERYDAY LIFE; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SHORT FORM 36; SJOEGREN SYNDROME; UNITED STATES; VALIDATION PROCESS;

EID: 20244367604     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2005.03074.x     Document Type: Article

References (32)

1. Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8.
2. Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J 1995;21:221-32.
3. Pepose JS, Akata RF, Pflugfelder SC, Voigt W. Mononuclear cell phenotypes and immunoglobulin gene arrangements in lacrimal gland biopsies from patients with Sjögren's Syndrome. Ophthalmology 1990;97:1599-605.
4. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's Syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
5. MGI Pharma, Inc. Salagen Indication Extended to Dry Mouth in Sjögren's Syndrome. Doctor's Guide Publishing: PSL group 1998, article 5b68e.
6. Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol 2001;45(Suppl. 2): S199-202.
7. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997; 75:281-6.
8. Schein OD, Hochberg MC, Munoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999;159: 1359-63.
9. Bandeen-Roche K, Munoz B, Tielsch JM, et al. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997;38:2469-75.
10. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8.
11. Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optom Vis Sci 2000;77: 357-63.
12. Caffery BE, Richter D, Simpson T, et al. CANDEES. The Canadian Dry Eye Epidemiol Study. Adv Exp Med Biol 1998;438:805-6.
13. Doughty MJ, Form D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997;74:624-31.
14. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995;233:555-8.
15. Begley CG, Caffery B, Chalmers RL, et al. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea 2002;21:664-70.
16. Begley CG, Caffery B, Nichols K, et al. Results of a dry eye questionnaire from optometric practices in North America. Adv Exp Med Biol 2002;506(Pt B):1009-16.
17. Fox RI, Michelson P. Approaches to the treatment of Sjögren's Syndrome. J Rheumatol 2000;61 (Suppl.):S15-21.
18. Sjögren's Syndrome Foundation. What is Sjögren's Syndrome? WebMDHealth: Cleveland Clinic 2002, article 2945.503.
19. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five year review. Cornea 2000;19:644-9.
20. Doughty MJ, Blades KA, Ibrahim N. Assessment of the number of eye symptoms and the impact of some confounding variables for office staff in non-air-conditioned buildings. Ophthalmic Physiol Opt 2002;22:143-55.
21. Wilson S. Dry eye disease: new paradigm, new treatment? Research to Prevent Blindness, 1-2. Available at http://www.rpbusa.org/library_content. php?document_id=5.
22. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne. Australia Ophthalmol 1998;105:1114-19.
23. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998;37: 1069-76.
24. Calonge M. The treatment of dry eye. Surv Ophthalmol 2001;45(Suppl. 2):S227-39.
25. Zhao J, Manthorpe R, Wollmer P. Surface activity of tear fluid in patients with primary Sjogren's syndrome. Clin Physiol Funct Imaging 2002;22: 24-7.
26. Ware JE. SF-36 Health Survey - Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
27. The EuroQoL Group. EuroQoL - a facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
28. Walters SJ, Campbell MJ. The use of bootstrap methods for analyzing health-related quality of life outcomes (particularly the SF-36). Session 3 presentation at the International Society for Quality of Life Research (ISOQOL) symposium: June 28, 2004; Boston, MA.
29. Kosinski M, Bjorner JB, Ware JE, et al. The responsiveness of headache impact scales scored using "classical" and "modern" psychometric methods: a reanalysis of three clinical trials. Qual Life Res 2003;12:903-12.
30. McHorney CA, Ware JE, Raczek AE. The MOS, 36-item short form health status survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
31. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for scoring and statistical analysis of SF-36 health profiles and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33(Suppl. 4):AS264-79.
32. Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye on patients' lives: comparisons to a US normative sample. Invest Ophthalmol Vis Sci 2005;46:46-50.